Glenn Goddard, EVP, Chief Financial Officer at Intellia Therapeutics, Inc. (NTLA), sold 4,854 shares at $37.21 ($181K) on 2023-01-04, disclosed to the SEC on 2023-01-06.
Open-market sale of $181k NTLA by EVP, Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $37.21 | 2,427 | $90K | 50.0% |
| 2 | $37.21 | 2,427 | $90K | 50.0% |
| Total | $37.21 avg | 4,854 | $181K | 100% |
| Filing → |
| NTLA | SELL | 2021-09-09 | $1.3M | — | Filing → |
| NTLA | SELL | 2021-09-01 | $5.0M | — | Filing → |
| NTLA | SELL | 2021-08-06 | $6.0M | — | Filing → |